Showing results (651-660 of 718) with videos related to

Sort By:
Pageof 72
Respiration; International Review of Thoracic Diseases|March 1, 2022
Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest PhysiciansMarek Lommatzsch, Klaus F Rabe, Christian Taube, et al.
Patient Preference and Adherence|December 9, 2024
Association of Patients' Knowledge on the Disease and Its Management with Indicators of Disease Severity and Individual Characteristics in Patients with Chronic Obstructive Pulmonary Disease (COPD): Results from COSYCONET 2Carolina Fischer, Maria Siakavara, Peter Alter, et al.
Respiratory Research|July 13, 2024
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)Franziska C Trudzinski, Rudolf A Jörres, Peter Alter, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
Intensive Care Medicine|December 11, 2019
Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 WorkgroupMichael Joannidis, Lui G Forni, Sebastian J Klein, et al.
Expert Review of Anti-Infective Therapy|July 4, 2018
Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trialsPhilipp Schuetz, Rebekka Bolliger, Meret Merker, et al.
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspectivePhilipp Schuetz, Robert Balk, Matthias Briel, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
Blood Advances|December 3, 2021
Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19Malgorzata Wygrecka, Anna Birnhuber, Benjamin Seeliger, et al.
The Lancet. Respiratory Medicine|April 27, 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)James D Chalmers, Eva Polverino, Megan L Crichton, et al.
Pageof 72